KAI1 expression in thyroid neoplasms: Its linkage with clinicopathologic features in papillary carcinoma

被引:12
作者
Ito, Y [1 ]
Yoshida, H [1 ]
Uruno, T [1 ]
Nakano, K [1 ]
Takamura, Y [1 ]
Miya, A [1 ]
Kobayashi, K [1 ]
Yokozawa, T [1 ]
Matsuzuka, F [1 ]
Kuma, K [1 ]
Miyauchi, A [1 ]
机构
[1] Kuma Hosp, Dept Surg, Chuo Ku, Kobe, Hyogo 6500011, Japan
关键词
KAI1; immunohistochemistry; thyroid carcinoma;
D O I
10.1078/0344-0338-00358
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
KAI1 is a metastasis suppressor gene located on human chromosome 11p11.2. Previous studies have shown that the down-regulation of KAI1 mRNA and decreased expression of its gene product are significantly linked to carcinoma progression, including metastatic ability. In this study, we investigated KAI1 protein expression in thyroid neoplasms. KAI1 overexpression was observed in 64.0% of papillary carcinoma cases, and the incidence was significantly higher than in cases of follicular carcinoma (20.0%) (p = 0.0001). In papillary carcinomas, decreased KAI1 expression was frequently observed in cases invading beyond the thyroid capsule (p = 0.001), as well as in lymph node metastases (p = 0.0047) and poorly differentiated lesions (p = 0.0299). Furthermore, in anaplastic carcinoma, the incidence of KAI1 overexpression was lower than in papillary carcinoma (p < 0.0001), and only 4.2% of the cases overexpressed this gene. These results suggest that KAI1 down-regulation is significantly related to the progression of papillary carcinoma, including lymph node metastasis, and its anaplastic transformation.
引用
收藏
页码:79 / 83
页数:5
相关论文
共 27 条
[1]  
ALDINGER KA, 1978, CANCER-AM CANCER SOC, V41, P2267, DOI 10.1002/1097-0142(197806)41:6<2267::AID-CNCR2820410627>3.0.CO
[2]  
2-7
[3]  
BRABANT G, 1993, CANCER RES, V53, P4987
[4]   KAI1, A METASTASIS SUPPRESSOR GENE FOR PROSTATE-CANCER ON HUMAN-CHROMOSOME 11P11.2 [J].
DONG, JT ;
LAMB, PW ;
RINKERSCHAEFFER, CW ;
VUKANOVIC, J ;
ICHIKAWA, T ;
ISAACS, JT ;
BARRETT, JC .
SCIENCE, 1995, 268 (5212) :884-886
[5]   Genomic organization of the human KAl1 metastasis-suppressor gene [J].
Dong, JT ;
Isaacs, WB ;
Barrett, JC ;
Isaacs, JT .
GENOMICS, 1997, 41 (01) :25-32
[6]  
Dong JT, 1996, CANCER RES, V56, P4387
[7]   GENE P53 MUTATIONS ARE RESTRICTED TO POORLY DIFFERENTIATED AND UNDIFFERENTIATED CARCINOMAS OF THE THYROID-GLAND [J].
DONGHI, R ;
LONGONI, A ;
PILOTTI, S ;
MICHIELI, P ;
DELLAPORTA, G ;
PIEROTTI, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1753-1760
[8]   PREFERENTIAL EXPRESSION OF THE CELL-ADHESION MOLECULE CD44 IN PAPILLARY THYROID-CARCINOMA [J].
FIGGE, J ;
DELROSARIO, AD ;
GERASIMOV, G ;
DEDOV, I ;
BRONSTEIN, M ;
TROSHINA, K ;
ALEXANDROVA, G ;
KALLAKURY, BVS ;
BUI, HX ;
BRATSLAVSKY, G ;
ROSS, JS .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1994, 61 (03) :203-211
[9]  
Friess H, 1998, INT J CANCER, V79, P349, DOI 10.1002/(SICI)1097-0215(19980821)79:4<349::AID-IJC7>3.0.CO
[10]  
2-V